Rising Danger of E-cigarettes in Brazil: Evali and Health Implications

Regulations by 2FIRSTS.ai
Dec.27.2023
Rising Danger of E-cigarettes in Brazil: Evali and Health Implications
The high number of smokers in Campo Grande, Brazil, has raised concerns as experts warn of a new lung disease caused by e-cigarettes.

According to recent reports from Brazilian news outlet Correiodoestado, data collected through telephone surveys (Vigitel 0) for monitoring risk and protective factors reveals a high number of smokers in the city. Among them, 6.9% are male and 8.6% are female.

 

As more and more individuals adopt the use of e-cigarettes, medical experts are issuing warnings about a newly emerging lung illness called Evali, specifically caused by the use of e-cigarettes.

 

Healthcare professionals are engaged in a battle against e-cigarettes, according to respiratory disease expert Henrique Ferreira de Brito, as these devices are deemed more harmful than conventional cigarettes.

 

Although e-cigarette devices, also known as Electronic Smoking Devices (DEF), do not burn tobacco, their nicotine content is higher than that of "regular" cigarettes, resulting in greater and faster dependency.

 

Doctors say that e-cigarettes have a higher dependency, contain higher levels of nicotine, and can reach the human brain faster, resulting in a dependency on nicotine additives. Therefore, in addition to the inherent dangers of nicotine itself, e-cigarettes also contain other substances different from traditional cigarettes that pose serious health risks.

 

The doctor further explained that these substances are associated with various diseases, including heart disease, lung disease, cardiovascular disease, cancer, and Evali.

 

The São Paulo Research Foundation (Fapesp) has published an article revealing a brief history of this new type of lung disease, which was first discovered in the United States in 2009.

 

At the time, many young people in their twenties, some of whom had never suffered from respiratory diseases before, were experiencing symptoms such as difficulty breathing, coughing, and chest pains in American hospitals. Additionally, many individuals also reported abdominal pain, nausea, vomiting, diarrhea, fatigue, fever, and weight loss.

 

According to this historical record, all patients have one common factor: they are all users of e-cigarettes. In Brazil, there have been recorded cases of Evali, some of which also exhibit typical symptoms of viral pneumonia caused by Covid-19.

 

A recent study conducted by the Brazilian Institute of Geography and Statistics (IBGE) revealed that the teenage e-cigarette usage rate in Campo Grande is the highest in Brazil, with 0.9% of ninth-grade students having already tried e-cigarettes.

 

Doctors have warned that the sale, import, distribution, and marketing of e-cigarettes are prohibited under Resolution of the Collegiate Board. Although the use itself is not banned, currently all buying and selling is prohibited. Young people are particularly susceptible to the allure of e-cigarettes and may mistakenly believe they are harmless. However, this is a lie, as e-cigarettes, even those without nicotine, pose significant health risks.

 

Doctors say that factors contributing to the difficulties of quitting smoking include the release of dopamine when nicotine is consumed. Users constantly crave that feeling, which leads to an escalation in both frequency and quantity of smoking. However, in addition to chemical dependence, there are also psychological and physiological dependencies.

 

In order to quit smoking, doctors recommend that besides the individual's determination, they should also have a medical team consisting of a nutritionist, a psychologist, and a pulmonary specialist to accompany them. These professionals will assist in changing habits and utilize medications that aid in improving the chemical dependency sensation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Juul Labs UK launches JUUL2 Peach flavour aimed at adult smokers
Juul Labs UK launches JUUL2 Peach flavour aimed at adult smokers
Juul Labs UK announced on January 1, 2026 the launch of a new JUUL2 Peach flavour, described as an adult-oriented addition that expands the JUUL2 flavour portfolio. The company said the flavour will roll out across the UK from January 1 through major retailers, wholesalers and convenience stores, offering adult smokers alternatives to transition away from cigarettes.
Jan.04 by 2FIRSTS.ai
Study: TikTok Content Frames Nicotine Pouches as “Trendy Accessories,” Diluting Risk Perception Among Youth
Study: TikTok Content Frames Nicotine Pouches as “Trendy Accessories,” Diluting Risk Perception Among Youth
A study published in JMIR Formative Research analyzed 132 TikTok videos related to nicotine pouches and found that platform content predominantly presents these products as a “youthful trend” rather than as smoking cessation tools. Health risks are underrepresented, the user base appears largely male, and this portrayal may influence how adolescents perceive the risks associated with nicotine products.
Dec.04 by 2FIRSTS.ai
Smoking Rate Drops to 17.9%, Vaping Rate Climbs to 9.3% in South Korea
Smoking Rate Drops to 17.9%, Vaping Rate Climbs to 9.3% in South Korea
The Korea Disease Control and Prevention Agency (KDCA) released its 2025 Community Health Survey results covering more than 230,000 adults. Traditional cigarette smoking dropped to 17.9%, down 1 percentage point from last year, while e-cigarette use increased to 9.3%, up 0.6 points. Overall tobacco product use stood at 22.1%, a slight decline from 2024 but still 0.5 points higher than 2019.
Dec.08 by 2FIRSTS.ai
Philip Morris Japan launches new IQOS SENTIA “Icy Red” flavor with icy menthol and red berry notes
Philip Morris Japan launches new IQOS SENTIA “Icy Red” flavor with icy menthol and red berry notes
Philip Morris Japan has announced the launch of a new SENTIA Icy Red tobacco stick for its IQOS ILUMA i and IQOS ILUMA heated tobacco devices, featuring an intense menthol profile with red fruit notes. The new product will roll out in stages from December across physical IQOS outlets, online channels and tobacco retailers nationwide in Japan, priced at 530 yen (approx. USD 3.4) per pack.
Dec.01 by 2FIRSTS.ai
Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia
Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia
Alfabet Labs, the parent company of FLONQ, has recently launched its new vaping brand ROQY in Russia, debuting two products: ROQY L and ROQY M. Both devices use a hybrid nicotine formulation combining nicotine salts and freebase nicotine and are each available in 19 flavors. The two products are now on sale via the official ROQY website as well as multiple online and offline retailers across Russia.
Nov.19 by 2FIRSTS.ai
Malaysia’s Cabinet Agrees in Principle to Nationwide Vape Ban
Malaysia’s Cabinet Agrees in Principle to Nationwide Vape Ban
Malaysia is accelerating efforts toward a nationwide ban on vaping, with the Health Ministry aiming to finalise the policy by 2026. Health Minister Dzulkefly Ahmad said the Cabinet has already agreed in principle to move toward a ban, stressing that the issue is no longer whether vaping will be banned, but when.
Dec.16 by 2FIRSTS.ai